Document Detail


Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound-Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies.
MedLine Citation:
PMID:  24666839     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The current diagnosis of prostate cancer (PCa) uses transrectal ultrasound-guided biopsy (TRUSGB). TRUSGB leads to sampling errors causing delayed diagnosis, overdetection of indolent PCa, and misclassification. Advances in multiparametric magnetic resonance imaging (mpMRI) suggest that imaging and selective magnetic resonance (MR)-guided biopsy (MRGB) may be superior to TRUSGB.
OBJECTIVE: To compare the diagnostic efficacy of the magnetic resonance imaging (MRI) pathway with TRUSGB.
DESIGN, SETTING, AND PARTICIPANTS: A total of 223 consecutive biopsy-naive men referred to a urologist with elevated prostate-specific antigen participated in a single-institution, prospective, investigator-blinded, diagnostic study from July 2012 through January 2013.
INTERVENTION: All participants had mpMRI and TRUSGB. Men with equivocal or suspicious lesions on mpMRI also underwent MRGB.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was PCa detection. Secondary outcomes were histopathologic details of biopsy and radical prostatectomy specimens, adverse events, and MRI reader performance. Sensitivity, specificity, negative predictive values (NPVs), and positive predictive values were estimated and basic statistics presented by number (percentage) or median (interquartile range).
RESULTS AND LIMITATIONS: Of 223 men, 142 (63.7%) had PCa. TRUSGB detected 126 cases of PCa in 223 men (56.5%) including 47 (37.3%) classed as low risk. MRGB detected 99 cases of PCa in 142 men (69.7%) with equivocal or suspicious mpMRI, of which 6 (6.1%) were low risk. The MRGB pathway reduced the need for biopsy by 51%, decreased the diagnosis of low-risk PCa by 89.4%, and increased the detection of intermediate/high-risk PCa by 17.7%. The estimated NPVs of TRUSGB and MRGB for intermediate/high-risk disease were 71.9% and 96.9%, respectively. The main limitation is the lack of long follow-up.
CONCLUSIONS: We found that mpMRI/MRGB reduces the detection of low-risk PCa and reduces the number of men requiring biopsy while improving the overall rate of detection of intermediate/high-risk PCa.
PATIENT SUMMARY: We compared the results of standard prostate biopsies with a magnetic resonance (MR) image-based targeted biopsy diagnostic pathway in men with elevated prostate-specific antigen. Our results suggest patient benefits of the MR pathway. Follow-up of negative investigations is required.
Authors:
Morgan R Pokorny; Maarten de Rooij; Earl Duncan; Fritz H Schröder; Robert Parkinson; Jelle O Barentsz; Leslie C Thompson
Related Documents :
12018109 - Renal angiomyolipoma with minimal fat.
18838849 - Ankle mri for anterolateral soft tissue impingement: increased accuracy with the use of...
9811139 - Mri in the study of distal primary myopathopies and of muscular alterations due to peri...
8972329 - Fast spin-echo mr imaging of the eye.
24192979 - Diffusion-weighted mri, (11)c-choline pet and (18)f-fluorodeoxyglucose pet for predicti...
19523519 - Quantification of adiposity in small rodents using micro-ct.
24808419 - Mri of hepatocellular carcinoma: an update of current practices.
24162519 - The evolution of degenerative marrow (modic) changes in the cervical spine in neck pain...
24791949 - An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weig...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-3-14
Journal Detail:
Title:  European urology     Volume:  -     ISSN:  1873-7560     ISO Abbreviation:  Eur. Urol.     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-3-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7512719     Medline TA:  Eur Urol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated repl...
Next Document:  Myocardial hydrophilic polymer emboli following cardiac catheterization: a case report and literatur...